NYMXF Alzheimer's treatment! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NYMXF Alzheimer's treatment!

NYMXF 0.106

-0.9%

Oct 31 10:45 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Demetre Deliyanakis who wrote (115)	8/6/1998 6:47:00 AM
From: Demetre Deliyanakis	Read Replies (1) of 132

I e-mailed Nymox yesterday with a few questions. They said that the urine test will be available this year. It does not require FDA approval. This is good news since it will allow them to market the test more quickly. However, I wonder if the medical community would use a test from a small company. I still think that Nymox will have to enter into a joint venture with a major drug company in order to have a chance of selling large numbers of tests. Does anyone know if any institutions own the stock other than Interinvest and the Caisse de Depot of Quebec? . I saw an article in the paper a few months ago which named these two institutional investors as shareholders.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next